Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

The Proportion of Ph+CD34(+)CD38(neg) Leukemic Stem Cells In the Bone Marrow of Newly Diagnosed Patients with Chronic Myeloid Leukemia (CML) In Chronic Phase (CP) Is Variable and Correlates with High Sokal Risk, High Leukocyte Count, Low Hemoglobin Concentration, Splenomegaly and Increased Hematological Toxicity During Initial TKI Therapy Data From a Randomized Phase II NordCML006 Study

Author:
  • Satu Mustjoki
  • Johan Richter
  • Gisela Barbany
  • Ingunn Dybedal
  • Thoas Fioretos
  • Tobias Gedde Dahl
  • Bjorn T. Gjertsen
  • Randi Hovland
  • Sari Jalkanen
  • Dag Josefsen
  • Perttu Koskenvesa
  • Carin Lassen
  • Kirsi Latvala
  • Waleed Majeed
  • Claes Malm
  • Berit Markevarn
  • Ali Moshfegh
  • Lotta Ohm
  • Tor Olofsson
  • Ulla Olsson Stromberg
  • Katrin Rapakko
  • Kari Remes
  • Jesper Stentoft
  • Leif Stenke
  • Merja Suominen
  • Sara Thunberg
  • Ole Weiss Bjerrum
  • Bengt Simonsson
  • Kimmo Porkka
  • Henrik Hjorth Hansen
Publishing year: 2010
Language: English
Pages: 291-292
Publication/Series: Blood
Volume: 116
Issue: 21
Document type: Conference paper: abstract
Publisher: American Society of Hematology

Keywords

  • Hematology

Other

52nd Annual Meeting of the American-Society-of-Hematology (ASH)
Published
  • ISSN: 1528-0020
Thoas Fioretos
E-mail: thoas [dot] fioretos [at] med [dot] lu [dot] se

Principal investigator

Translational Genomic and Functional Studies of Leucemia

+46 46 222 45 95

+46 70 334 33 67

BMC C13

66

Professor

Division of Clinical Genetics

+46 46 222 45 95

+46 70 334 33 67

BMC C13

66

Professor

Translational Genomic and Functional Studies of Leucemia

+46 46 222 45 95

+46 70 334 33 67

BMC C13

66